Olema Pharmaceuticals, Inc. (OLMA)
10.27
-0.52
(-4.82%)
USD |
NASDAQ |
Aug 28, 16:00
10.27
0.00 (0.00%)
After-Hours: 20:00
Olema Pharmaceuticals Total Assets (Quarterly) : 486.58M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 486.58M |
| March 31, 2026 | 530.64M |
| December 31, 2025 | 677.32M |
| September 30, 2025 | 352.45M |
| June 30, 2025 | 382.00M |
| March 31, 2025 | 409.64M |
| December 31, 2024 | 556.07M |
| September 30, 2024 | 230.17M |
| June 30, 2024 | 254.56M |
| March 31, 2024 | 263.69M |
| December 31, 2023 | 276.94M |
| September 30, 2023 | 292.80M |
| Date | Value |
|---|---|
| June 30, 2023 | 177.62M |
| March 31, 2023 | 195.77M |
| December 31, 2022 | 215.64M |
| September 30, 2022 | 232.00M |
| June 30, 2022 | 250.60M |
| March 31, 2022 | 277.42M |
| December 31, 2021 | 295.94M |
| September 30, 2021 | 309.80M |
| June 30, 2021 | 322.23M |
| March 31, 2021 | 331.30M |
| December 31, 2020 | 342.72M |
| September 30, 2020 | 130.68M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 56.01M |
| Shareholders Equity (Quarterly) | 430.56M |
| Debt to Equity Ratio | 0.0085 |
| Current Ratio | 8.863 |
| Net Debt Paydown Yield | -0.05% |